Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 3Na.HO7P2 |
| Molecular Weight | 243.9206 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[Na+].OP([O-])(=O)OP([O-])([O-])=O
InChI
InChIKey=MLIKYFGFHUYZAL-UHFFFAOYSA-K
InChI=1S/3Na.H4O7P2/c;;;1-8(2,3)7-9(4,5)6/h;;;(H2,1,2,3)(H2,4,5,6)/q3*+1;/p-3
| Molecular Formula | Na |
| Molecular Weight | 22.9898 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | HO7P2 |
| Molecular Weight | 174.9513 |
| Charge | -3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://books.google.ru/books?id=cPjjBwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=falseCurator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/11401820 | https://www.ncbi.nlm.nih.gov/pubmed/27061894 | http://www.food-info.net/uk/e/e450.htm
Sources: https://books.google.ru/books?id=cPjjBwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=false
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/11401820 | https://www.ncbi.nlm.nih.gov/pubmed/27061894 | http://www.food-info.net/uk/e/e450.htm
Inorganic pyrophosphate (PPi ) has long been known as a by-product of many intracellular biosynthetic reactions. PPi plays the regulatory role in living systems, such as activities of enzymes, fidelity of syntheses of macromolecules, and proliferation of cells. PPi is used as a biochemical energy source instead of ATP especially in bacteria, protists, and plants. PPi may also regulate the formation and dissolution of bone as well as pathologic calcification of soft tissues and the formation of urinary stones. The formation of calcium pyrophosphate dihydrate crystals in the extracellular fluids of joints cause the disease called pseudogout. Sodium, potassium and calcium pyrophosphates (E450) are used as food additives as buffers and emulsifiers.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0030282 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | Stannous Pyrophosphate Approved Usehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30046b6b-09ea-46b1-8e60-61c53e1e7282 |
|||
| Diagnostic | Stannous Pyrophosphate Approved Usehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30046b6b-09ea-46b1-8e60-61c53e1e7282 |
|||
| Diagnostic | Stannous Pyrophosphate Approved Usehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30046b6b-09ea-46b1-8e60-61c53e1e7282 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Antiviral effects of phosphonoformate (PFA, foscarnet sodium). | 1982 |
|
| PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase. | 1986 May |
|
| Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance. | 1993 Dec 14 |
|
| Biochemical characterization of HIV-1 reverse transcriptases encoding mutations at amino acid residues 161 and 208 involved in resistance to phosphonoformate. | 1998 Dec 15 |
|
| Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz. | 2005 Jan |
|
| Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. | 2008 Apr 10 |
Sample Use Guides
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:42:43 UTC 2023
by
admin
on
Fri Dec 15 19:42:43 UTC 2023
|
| Record UNII |
AR7OGW33N1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
AR7OGW33N1
Created by
admin on Fri Dec 15 19:42:43 UTC 2023 , Edited by admin on Fri Dec 15 19:42:43 UTC 2023
|
PRIMARY | |||
|
238-735-6
Created by
admin on Fri Dec 15 19:42:43 UTC 2023 , Edited by admin on Fri Dec 15 19:42:43 UTC 2023
|
PRIMARY | |||
|
AR7OGW33N1
Created by
admin on Fri Dec 15 19:42:43 UTC 2023 , Edited by admin on Fri Dec 15 19:42:43 UTC 2023
|
PRIMARY | |||
|
DTXSID70872534
Created by
admin on Fri Dec 15 19:42:43 UTC 2023 , Edited by admin on Fri Dec 15 19:42:43 UTC 2023
|
PRIMARY | |||
|
300
Created by
admin on Fri Dec 15 19:42:43 UTC 2023 , Edited by admin on Fri Dec 15 19:42:43 UTC 2023
|
PRIMARY | |||
|
14691-80-6
Created by
admin on Fri Dec 15 19:42:43 UTC 2023 , Edited by admin on Fri Dec 15 19:42:43 UTC 2023
|
PRIMARY | |||
|
2046778
Created by
admin on Fri Dec 15 19:42:43 UTC 2023 , Edited by admin on Fri Dec 15 19:42:43 UTC 2023
|
PRIMARY | |||
|
161081
Created by
admin on Fri Dec 15 19:42:43 UTC 2023 , Edited by admin on Fri Dec 15 19:42:43 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
